Maria Foss-Freitas

12PUBLICATIONS
81CO-AUTHORS
Molecular targetsMedical biochemistry - lipidsEpigenetics (incl. genome methylation and epigenomics)Food properties (incl. characteristics and health benefits)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Nov 05, 2025
Advances of pharmacological therapies in lipodystrophy syndromes: current evidence and future directions.

Ozge Besci, Merve Celik Guler, Maria Cristina Foss-Freitas

|Oct 11, 2025
Calf skinfold measurements as a diagnostic tool for lipodystrophy syndromes: a cross-sectional study.

Grayce Ellen da Cruz Paiva Lima, Fabia Karine de Moura Lopes, Jessica Silveira Araújo

|Jun 30, 2025
Genetics Evaluation Outcomes From an Academic Multidisciplinary Atypical Diabetes Program.

Colby L Chase, Marie-Louise Accardo, Veronica Greve

|Jan 13, 2025
Tirzepatide for Lipodystrophy.

Rasimcan Meral, Merve Celik Guler, Diarratou Kaba

|Jul 09, 2024
Early B-cell transcription factor-2 defect as a novel cause of lipodystrophy: disruption of the adipose tissue character and integrity.

Maria C Foss-Freitas, Donatella Gilio, Andre Monteiro da Rocha

|Nov 22, 2023
Preclinical, randomized phase 1, and compassionate use evaluation of REGN4461, a leptin receptor agonist antibody for leptin deficiency.

Judith Y Altarejos, Jeffrey Pangilinan, Simona Podgrabinska

Pageof 2